STOCK TITAN
  1. Home
  2. News
  3. NCTY

The9 Limited - NCTY STOCK NEWS

Welcome to our dedicated news page for The9 (Ticker: NCTY), a resource for investors and traders seeking the latest updates and insights on The9.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect The9's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of The9's position in the market.

News
The9 Limited Achieved 66% Increase in Net Revenues and Turned Net Loss into Net Income for the Year Ended December 31, 2023
Rhea-AI Summary
The9 achieved a 66% increase in net revenues and turned net loss into net income for the year ended December 31, 2023. The company's net revenues rose from RMB108 million in 2022 to RMB179 million in 2023, while net income reached RMB13 million compared to a net loss of RMB975 million in 2022. The Chairman and CEO highlighted the growth in the cryptocurrency mining business and the company's entry into AI applications in various industries.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.53%
Tags
none
-
News
A New Generation of Antidepressant Drug Precision Treatment Based on Revolutionary AI Technology is Born
Rhea-AI Summary
The9 (NCTY) investee WM Therapeutics Co., achieves breakthroughs in antidepressant drug precision treatment using GenAI technology. The new clinical trial results show significant progress in identifying effective subtypes for depression treatment, offering hope to patients worldwide.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.55%
Tags
AI
-
News
The9 Signed a Definitive Share Purchase Agreement to Invest in GenAI LLM Digital Precision Medicine Platform for Brain Disease WM Therapeutic
Rhea-AI Summary
The9 (NCTY) has signed a definitive agreement with WM Therapeutic to purchase additional shares, totaling 30% ownership. The agreement includes cash payment and issuance of restricted shares. WM Therapeutic focuses on GenAI large language model brain disease screening platform and AI drug clinical research platform.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.79%
Tags
none
News
/C O R R E C T I O N -- The9 Limited/
Rhea-AI Summary
The9 (NCTY) has signed a definitive share purchase agreement to invest in GenAI LLM Digital Precision Medicine Platform for Brain Disease WM Therapeutic. The agreement allows The9 to purchase an additional 21.7% shares of WM Therapeutic, increasing its ownership to 30%. The company is also granted a purchase option to acquire up to 51% of WM Therapeutic. WM Therapeutic focuses on developing AI-based solutions for brain diseases utilizing omics data analysis technology. The agreement involves cash consideration of US$1.5 million and issuance of 251,290,500 restricted Class A ordinary shares to WM Therapeutic. These shares will be subject to lock-up conditions based on The9's market capitalization milestones. The partnership aims to address various central nervous system diseases through innovative technology and strategic collaborations.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.79%
Tags
none
-
News
The9 Signed a Legally Binding Term Sheet to Acquire a Leading AIGC Driven Digital Human SaaS Platform ShenMa
Rhea-AI Summary
The9 Limited (Nasdaq: NCTY) announced the signing of a term sheet to purchase 51% shares of Shenma Limited, a digital human SaaS platform, using cash and restricted shares. Shenma's platform offers AI-generated content and digital human creation services, with plans for monetization and growth. The acquisition aims to capitalize on the growing AIGC market in China and expand The9's presence in the AI industry.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.64%
Tags
acquisition
-
News
The9 Signed a Legally Binding Term Sheet with a Leading AI SaaS Legal Service Platform 365LAWHELP.COM
Rhea-AI Summary
The9 Limited (NCTY) announces the acquisition of 19% shares of Fazhidao, a leading AI SaaS legal service platform in China, with a purchase option for up to 51% shares. Fazhidao's gross sales exceeded US$50 million in 2023, offering various legal services powered by AI technology. The investment includes cash and restricted shares, aiming for global expansion and growth in paid subscribers.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.85%
Tags
AI
News
The9's Chairman and CEO to Purchase No More Than 10% of The9 ADSs in the Open Market
Rhea-AI Summary
The9 Limited (Nasdaq: NCTY) announced that its Chairman and CEO, Jun Zhu, intends to use personal funds to purchase up to 10% of the Company's outstanding American depositary shares in the open market. This move reflects Mr. Zhu's confidence in the company's future and is in accordance with applicable rules and regulations.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
15.88%
Tags
none
-
News
The9 Limited Raised US$12 million in a Private Placement Transaction to Fund Business Growth
Rhea-AI Summary
The9 Limited (Nasdaq: NCTY) has closed a private placement securities purchase transaction, raising a total of US$12 million. The transaction includes the sale and issuance of 150,000,000 Class A ordinary shares, a two-year 3% per annum convertible promissory note, and warrants to purchase an aggregate of 120,000,000 Class A ordinary shares. The Company plans to use the proceeds to fund future growth.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
16.2%
Tags
none
-
News
The9 Limited to Hold Annual General Meeting on December 22, 2023
Rhea-AI Summary
The9 Limited (Nasdaq: NCTY) announces the annual general meeting of shareholders at BNY Mellon Office, Hong Kong, on December 22, 2023. No proposal will be submitted for shareholder approval. The meeting will serve as an open forum for shareholders and beneficial owners to discuss Company affairs with management. The Record Date is December 8, 2023, for determining the holders of the Company's ordinary shares entitled to attend the meeting. The Company has filed its annual report on Form 20-F with the SEC, including audited financial statements for the fiscal year ended December 31, 2022.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.19%
Tags
none
News
The9 Limited Filed Annual Report on Form 20-F for Fiscal Year 2022 and Adopted Tenth Amended and Restated 2004 Stock Option Plan
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.09%
Tags
earnings
Stock NCTY logo
The9 Limited

Nasdaq:NCTY

NCTY Rankings

#4869 Ranked by Market Cap
#3998 Ranked by Stock Gains
N/A Ranked by Dividends

NCTY Stock Data

34.01M
801.83M
1.53%
0.48%
1.17%
Software Publishers
Information
Link
China
Shanghai

About NCTY

The9 Ltd. is a Shanghai-based online game operator which had the exclusive licence to operate and distribute World of Warcraft in China, a licence it secured after successfully aiding Webzen Games with the distribution of Mu Online in China.